Table 3.

Treatment‐related adverse events (N = 18)

Adverse event	Any grade	Grade ≥ 3
	No. of patients (%)
Anemia	1 (5.6)	0
Arthralgia	1 (5.6)	0
Nausea	1 (5.6)	0
Diarrhea	1 (5.6)	0
Amylase increased	3 (16.7)	1 (5.6)
Lipase increased	2 (11.1)	1 (5.6)
AST increased	1 (5.6)	0
Hyperthyroidism	1 (5.6)	0
Hypothyroidism	1 (5.6)	0
Dyspnea	1 (5.6)	0
Pneumonitis	3 (16.7)	1 (5.6)
Pruritus	4 (22.2)	1 (5.6)
Rash	4 (22.2)	0